(Q37956379)

25 August 2017

title

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity (English)

1 reference

25 August 2017

0 references

1 reference

1 reference

5

Geert Leroux-Roels

0 references

author name string

Adrian Cassidy

1

1 reference

25 August 2017

Sally Mossman

2

1 reference

25 August 2017

Antonio Olivieri

3

1 reference

25 August 2017

Marc De Ridder

4

1 reference

25 August 2017

publication date

1 December 2011

1 reference

Expert Review of Vaccines

25 August 2017

published in

1 reference

25 August 2017

volume

10

1 reference

25 August 2017

issue

12

1 reference

25 August 2017

page(s)

1709-1715

1 reference

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Risks of chronicity following acute hepatitis B virus infection: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

New immunization initiatives and progress toward the global control of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Hepatitis B vaccine: risks and benefits of universal neonatal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Comprehensive control (or elimination) of hepatitis B virus transmission in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

The global impact of vaccination against hepatitis B: a historical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

A new algorithm for deduction of hepatitis B surface antigen subtype determinants from the amino acid sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Subtype specificity of anti-HBs antibodies produced by human B-cell lines isolated from normal individuals vaccinated with recombinant hepatitis B vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Geographical and genetic diversity of the human hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Epidemiology of hepatitis B and C viruses: a global overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Accumulation of substrates of the anaphase-promoting complex (APC) during human cytomegalovirus infection is associated with the phosphorylation of Cdh1 and the dissociation and relocalization of APC subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Nucleic acid testing to detect HBV infection in blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Legend of hepatitis B vaccination: the Taiwan experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

The impact of the hepatitis B virus vaccine on the incidence of hepatitis B virus-associated membranous nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Hepatitis B virus vaccine failure resulting in chronic hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

A comparative epidemiological study of hepatitis B and hepatitis D virus infections in Yanomami and Piaroa Amerindians of Amazonas State, Venezuela

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Phylogenetic analysis of hepatitis B virus genotype F complete genome sequences from Chilean patients with chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Hepatitis B virus genotypes in children and adolescents in Japan: before and after immunization for the prevention of mother to infant transmission of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Diagnostic strategy for occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.151

21 January 2018

Identifiers

DOI

10.1586/ERV.11.151

1 reference

25 August 2017

1 reference